Cassava Sciences Inc (SAVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -32,385 | -18,213 | -8,651 | -3,526 | -6,334 |
| Depreciation Amortization | 534 | 221 | 9 | 1 | 22 |
| Accounts payable and accrued liabilities | 6,215 | 1,434 | 1,001 | -47 | 458 |
| Other Working Capital | -104 | -5,454 | 532 | 969 | 288 |
| Other Operating Activity | -4,456 | -197 | -336 | 297 | 184 |
| Operating Cash Flow | $-30,196 | $-22,209 | $-7,445 | $-2,306 | $-5,382 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -22,214 | -22,114 | -73 | N/A | 360 |
| Investing Cash Flow | $-22,214 | $-22,114 | $-73 | $0 | $360 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 192,341 | 192,341 | 192,266 | 190,992 | 75,447 |
| Financing Cash Flow | $192,341 | $192,341 | $192,266 | $190,992 | $75,447 |
| Beginning Cash Position | 93,506 | 93,506 | 93,506 | 93,506 | 23,081 |
| End Cash Position | 233,437 | 241,524 | 278,254 | 282,192 | 93,506 |
| Net Cash Flow | $139,931 | $148,018 | $184,748 | $188,686 | $70,425 |
| Free Cash Flow | |||||
| Operating Cash Flow | -30,196 | -22,209 | -7,445 | -2,306 | -5,382 |
| Capital Expenditure | -22,214 | -22,114 | -73 | 0 | N/A |
| Free Cash Flow | -52,410 | -44,323 | -7,518 | -2,306 | -5,382 |